These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
473 related items for PubMed ID: 17229979
21. [What have we learned from converting enzyme inhibitors on renin-angiotensin system?]. Waeber B, Nussberger J, Brunner HR. Rev Prat; 1992 Dec 15; 42(20):2529-32. PubMed ID: 1338608 [Abstract] [Full Text] [Related]
22. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure. Mori J, Zhang L, Oudit GY, Lopaschuk GD. J Mol Cell Cardiol; 2013 Oct 15; 63():98-106. PubMed ID: 23886814 [Abstract] [Full Text] [Related]
23. New evidence for brain angiotensin and for its role in hypertension. Phillips MI. Fed Proc; 1983 Jul 15; 42(10):2667-72. PubMed ID: 6305729 [Abstract] [Full Text] [Related]
24. Angiotensin-converting enzyme-independent pathways of angiotensin II formation in human tissues and cardiovascular diseases. Urata H, Nishimura H, Ganten D, Arakawa K. Blood Press Suppl; 1996 Jul 15; 2():22-8. PubMed ID: 8913536 [Abstract] [Full Text] [Related]
26. Multiple pathways of angiotensin I conversion and their functional role in the canine penile corpus cavernosum. Iwamoto Y, Song K, Takai S, Yamada M, Jin D, Sakaguchi M, Ueda H, Katsuoka Y, Miyazaki M. J Pharmacol Exp Ther; 2001 Jul 15; 298(1):43-8. PubMed ID: 11408523 [Abstract] [Full Text] [Related]
27. Angiotensin II upregulates renin-angiotensin system in human isolated T lymphocytes. Coppo M, Boddi M, Bandinelli M, Degl'innocenti D, Ramazzotti M, Marra F, Galastri S, Abbate R, Gensini GF, Poggesi L. Regul Pept; 2008 Nov 29; 151(1-3):1-6. PubMed ID: 18723052 [Abstract] [Full Text] [Related]
28. Potential of renin inhibition in cardiovascular disease. Stanton A. J Renin Angiotensin Aldosterone Syst; 2003 Mar 29; 4(1):6-10. PubMed ID: 12692747 [Abstract] [Full Text] [Related]
29. The renin-angiotensin system and vascular function. The role of angiotensin II, angiotensin-converting enzyme, and alternative conversion of angiotensin I. Roks A, Buikema H, Pinto YM, van Gilst WH. Heart Vessels; 1997 Mar 29; Suppl 12():119-24. PubMed ID: 9476561 [Abstract] [Full Text] [Related]
30. Involvement of chymase-mediated angiotensin II generation in blood pressure regulation. Li M, Liu K, Michalicek J, Angus JA, Hunt JE, Dell'Italia LJ, Feneley MP, Graham RM, Husain A. J Clin Invest; 2004 Jul 29; 114(1):112-20. PubMed ID: 15232618 [Abstract] [Full Text] [Related]
31. Biosynthesis and physio-pharmacological actions of angiotensin peptides: 1. Synthetic enzymes. Haulică I, Bild W, Rădăşanu O. Rev Med Chir Soc Med Nat Iasi; 2006 Jul 29; 110(1):167-72. PubMed ID: 19292099 [Abstract] [Full Text] [Related]
32. The ovarian renin-angiotensin system in reproductive physiology. Yoshimura Y. Front Neuroendocrinol; 1997 Jul 29; 18(3):247-91. PubMed ID: 9237079 [Abstract] [Full Text] [Related]
33. Pathological roles of angiotensin II produced by mast cell chymase and the effects of chymase inhibition in animal models. Miyazaki M, Takai S, Jin D, Muramatsu M. Pharmacol Ther; 2006 Dec 29; 112(3):668-76. PubMed ID: 16837049 [Abstract] [Full Text] [Related]
34. Measurement of the renin-angiotensin system in heart failure. Kim SD. Biol Res Nurs; 2000 Jan 29; 1(3):210-26. PubMed ID: 11232216 [Abstract] [Full Text] [Related]
35. Angiotensin II formation in the human heart: an ACE or non-ACE-mediated pathway? Kokkonen JO, Saarinen J, Kovanen PT. Ann Med; 1998 Aug 29; 30 Suppl 1():9-13. PubMed ID: 9800878 [Abstract] [Full Text] [Related]
36. Novel Cardiac Intracrine Mechanisms Based on Ang-(1-12)/Chymase Axis Require a Revision of Therapeutic Approaches in Human Heart Disease. Reyes S, Varagic J, Ahmad S, VonCannon J, Kon ND, Wang H, Groban L, Cheng CP, Dell'Italia LJ, Ferrario CM. Curr Hypertens Rep; 2017 Feb 29; 19(2):16. PubMed ID: 28233239 [Abstract] [Full Text] [Related]
37. Interactions of angiotensin-converting enzyme, kinins and nitric oxide in circulation and the beneficial effects of ACE inhibitors in cardiovascular diseases. Magen E, Viskoper RJ. Isr Med Assoc J; 2000 Dec 29; 2(12):929-34. PubMed ID: 11344778 [Abstract] [Full Text] [Related]
38. [Renin-angiotensin system and its role in cardiovascular physiopathology and therapy]. Castro-Chaves P, Leite-Moreira AF. Rev Port Cardiol; 2004 May 29; 23 Suppl 2():II61-77. PubMed ID: 15222251 [Abstract] [Full Text] [Related]
39. Impact of angiotensin II on the kidney: does an angiotensin II receptor blocker make sense? Hollenberg NK. Am J Kidney Dis; 2000 Sep 29; 36(3 Suppl 1):S18-23. PubMed ID: 10986155 [Abstract] [Full Text] [Related]